Andrea Maggioni

Dr. Andrea Maggioni is a Research Fellow in Cancer Glycobiology at Griffith University's Institute for Biomedicine and Glycomics. He holds a BSc (Honors) in Molecular and Cell Biology from Università degli Studi di Milano and a PhD in Biomedical Sciences from Griffith University. His research focuses on glycobiology, cancer biology, and antiviral therapies, with notable contributions to understanding glycan-receptor interactions, viral entry mechanisms, and enzyme inhibitors.

Education:

• BSc (Hons), Molecular and Cell Biology, Università degli Studi di Milano (2001)
• PhD, Griffith University (2011)
• Certificate in Immunology, Harvard Medical School (2024–present)

Research Interests: Andrea's work bridges glycobiology and biomedical applications, including cancer immunotherapy biomarkers, viral pathogenesis (e.g., rotavirus, parechovirus), and drug design targeting enzymes like sialidase. He explores glycosylation roles in stem cell biology and employs advanced techniques such as NMR spectroscopy and mass spectrometry.

Grants & Projects:

• Leading a $250k grant to study melanoma biomarkers (Hay Family Benevolent Fund, 2023–2028)
• Co-investigator on $498k equipment grant for glycobiology research (Griffith University, 2023)
• Previous funding from Society for Glycobiology (2014 Travel Award) and Laing O'Rourke (2015)

Supervision: Associate supervisor for six ongoing doctoral/master's projects on topics like exosome glycointeractomes and cancer enzyme inhibition strategies.

Awards:

• 2014 Travel Award, Society for Glycobiology

Labs & Affiliations: Active in Griffith's Institute for Biomedicine and Glycomics, focusing on translational research in glycobiology and cancer. Collaborates internationally on antiviral drug discovery and immune modulation studies.